Yang, J.-H.; Wang, P.-H.; Pan, S.-W.; Wei, Y.-F.; Chen, C.-Y.; Lee, H.-S.; Shu, C.-C.; Wu, T.-S.
Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin. Antibiotics 2022, 11, 571.
https://doi.org/10.3390/antibiotics11050571
AMA Style
Yang J-H, Wang P-H, Pan S-W, Wei Y-F, Chen C-Y, Lee H-S, Shu C-C, Wu T-S.
Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin. Antibiotics. 2022; 11(5):571.
https://doi.org/10.3390/antibiotics11050571
Chicago/Turabian Style
Yang, Jeng-How, Ping-Huai Wang, Sheng-Wei Pan, Yu-Feng Wei, Chung-Yu Chen, Ho-Sheng Lee, Chin-Chung Shu, and Ting-Shu Wu.
2022. "Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin" Antibiotics 11, no. 5: 571.
https://doi.org/10.3390/antibiotics11050571
APA Style
Yang, J.-H., Wang, P.-H., Pan, S.-W., Wei, Y.-F., Chen, C.-Y., Lee, H.-S., Shu, C.-C., & Wu, T.-S.
(2022). Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin. Antibiotics, 11(5), 571.
https://doi.org/10.3390/antibiotics11050571